news
Scmp World
2026-06-06
Biotech Firms Race to Reverse Aging, Targeting a US$610 Billion Longevity Market
Biotechnology firms are investing heavily in research to reverse the aging process, viewing it as a programmable biological system. The goal is to target the burgeoning longevity market.